During the past decade, Laura And Isaac Perlmutter Cancer Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laura And Isaac Perlmutter Cancer Center" #1 sponsor was "NYU Langone Health" with 3 trials, followed by "Regeneron Pharmaceuticals" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Celldex Therapeutics" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laura And Isaac Perlmutter Cancer Center" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Laura And Isaac Perlmutter Cancer Center" are "Melanoma" (3 trials), "Advanced Malignancies" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Neoplasm Metastasis" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Laura And Isaac Perlmutter Cancer Center" in a lesser frequency.

Most popular intervention types in "Laura And Isaac Perlmutter Cancer Center" are "Drug" (13 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (3 trials), "AZD1775" (1 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laura And Isaac Perlmutter Cancer Center" are 15 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Laura And Isaac Perlmutter Cancer Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Laura And Isaac Perlmutter Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Laura And Isaac Perlmutter Cancer Center, 10 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".